Connect with us

CRIME AND SECURITY

NAFDAC Highlights Regulatory Milestones, Digital Innovation and Local Pharmaceutical Production at IPRP Meeting

Published

on

Spread the love

NAFDAC Highlights Regulatory Milestones, Digital Innovation and Local Pharmaceutical Production at IPRP Meeting

The Director-General of NAFDAC, Prof. Mojisola Adeyeye, has highlighted the Agency’s regulatory milestones in system strengthening, digital innovation, enforcement, local pharmaceutical production and international collaboration at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting in Prague, Czech Republic.

During the Agency’s Regulatory Update presentation at the meeting held from 18 – 19 November 2026, the DG highlighted NAFDAC’s sustained World Health Organisation (WHO) Maturity Level 3 status and ongoing transition towards Maturity Level 4, supported by digital initiatives including IRIMS, i-PMS, GMPi, AI-assisted Technical Screening Tools and the revised Med Safety App.

Between January and August 2026, NAFDAC recorded 5,542 enforcement activities, 213 raids, 821 product seizures, 179 premises closures, 52 arrests and 221 sanctions. The Agency also destroyed unwholesome products valued at approximately ₦22.73 billion in 22 destruction exercises.

The presentation further highlighted progress under NAFDAC’s 5+5 Policy, with over 70 per cent of finished pharmaceutical products under the policy and Ceiling 36 now locally manufactured, as well as the Agency’s growing role in regional regulatory cooperation.

NAFDAC has hosted regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity building and institutional benchmarking. Nigeria also ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on 25 October 2026.

These milestones underscore NAFDAC’s ongoing efforts to strengthen regulatory systems, advance digital transformation, promote local pharmaceutical manufacturing and deepen regulatory cooperation to safeguard public health.

 

 

 


Spread the love
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *